These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9632994)

  • 1. AIDS vaccine development in primate models.
    Almond NM; Heeney JL
    AIDS; 1998; 12 Suppl A():S133-40. PubMed ID: 9632994
    [No Abstract]   [Full Text] [Related]  

  • 2. Primate models of AIDS vaccine development.
    Lamb-Wharton RJ; Joag SV; Stephens EB; Narayan O
    AIDS; 1997; 11 Suppl A():S121-6. PubMed ID: 9451975
    [No Abstract]   [Full Text] [Related]  

  • 3. AIDS vaccine models: challenging challenge viruses.
    Feinberg MB; Moore JP
    Nat Med; 2002 Mar; 8(3):207-10. PubMed ID: 11875482
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV/AIDS in China. Vaccine development with a distinctly Chinese flavor.
    Cohen J
    Science; 2004 Jun; 304(5676):1437. PubMed ID: 15178780
    [No Abstract]   [Full Text] [Related]  

  • 5. Candidate vaccines protect macaques against primate immunodeficiency viruses.
    Stott J; Hu SL; Almond N
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S265-70. PubMed ID: 9814954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First updated and revised survey of worldwide HIV and SIV vaccine challenge studies in nonhuman primates: progress in first and second order studies.
    Warren JT; Dolatshahi M
    J Med Primatol; 1993; 22(2-3):203-35. PubMed ID: 8411110
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine.
    Bhardwaj N; Walker BD
    Nat Med; 2003 Jan; 9(1):13-4. PubMed ID: 12514710
    [No Abstract]   [Full Text] [Related]  

  • 8. Nonhuman primate models for HIV vaccine development.
    Letvin NL
    Immunodefic Rev; 1992; 3(3):247-60. PubMed ID: 1510838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospects for live attenuated HIV.
    Desrosiers RC
    Nat Med; 1998 Sep; 4(9):982. PubMed ID: 9734368
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV vaccine design: insights from live attenuated SIV vaccines.
    Koff WC; Johnson PR; Watkins DI; Burton DR; Lifson JD; Hasenkrug KJ; McDermott AB; Schultz A; Zamb TJ; Boyle R; Desrosiers RC
    Nat Immunol; 2006 Jan; 7(1):19-23. PubMed ID: 16357854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of primate models for AIDS.
    Haigwood NL
    AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIDS vaccines show promise in primates.
    Clin Infect Dis; 2001 Oct; 33(7):i-ii. PubMed ID: 11592258
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV vaccine development: perspective.
    Bolognesi DP
    Biotechnol Ther; 1991; 2(1-2):205-11. PubMed ID: 1845122
    [No Abstract]   [Full Text] [Related]  

  • 14. The primate connection.
    Trivedi B
    Nature; 2010 Jul; 466(7304):S5. PubMed ID: 20631704
    [No Abstract]   [Full Text] [Related]  

  • 15. [HIV vaccine].
    Matano T
    Nihon Rinsho; 2005 May; 63 Suppl 5():659-65. PubMed ID: 15954426
    [No Abstract]   [Full Text] [Related]  

  • 16. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.
    Shiver JW; Fu TM; Chen L; Casimiro DR; Davies ME; Evans RK; Zhang ZQ; Simon AJ; Trigona WL; Dubey SA; Huang L; Harris VA; Long RS; Liang X; Handt L; Schleif WA; Zhu L; Freed DC; Persaud NV; Guan L; Punt KS; Tang A; Chen M; Wilson KA; Collins KB; Heidecker GJ; Fernandez VR; Perry HC; Joyce JG; Grimm KM; Cook JC; Keller PM; Kresock DS; Mach H; Troutman RD; Isopi LA; Williams DM; Xu Z; Bohannon KE; Volkin DB; Montefiori DC; Miura A; Krivulka GR; Lifton MA; Kuroda MJ; Schmitz JE; Letvin NL; Caulfield MJ; Bett AJ; Youil R; Kaslow DC; Emini EA
    Nature; 2002 Jan; 415(6869):331-5. PubMed ID: 11797011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.
    Letvin NL; Huang Y; Chakrabarti BK; Xu L; Seaman MS; Beaudry K; Korioth-Schmitz B; Yu F; Rohne D; Martin KL; Miura A; Kong WP; Yang ZY; Gelman RS; Golubeva OG; Montefiori DC; Mascola JR; Nabel GJ
    J Virol; 2004 Jul; 78(14):7490-7. PubMed ID: 15220422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuated HIV vaccine: caveats.
    Ruprecht RM; Baba TW; Liska V
    Science; 1996 Mar; 271(5257):1790-2. PubMed ID: 8596941
    [No Abstract]   [Full Text] [Related]  

  • 19. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
    Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges.
    Ellenberger D; Otten RA; Li B; Aidoo M; Rodriguez IV; Sariol CA; Martinez M; Monsour M; Wyatt L; Hudgens MG; Kraiselburd E; Moss B; Robinson H; Folks T; Butera S
    Virology; 2006 Aug; 352(1):216-25. PubMed ID: 16725169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.